<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04619108</url>
  </required_header>
  <id_info>
    <org_study_id>Thrombosomes Expanded Access</org_study_id>
    <nct_id>NCT04619108</nct_id>
  </id_info>
  <brief_title>Thrombosomes for Expanded Access Use</brief_title>
  <official_title>Thrombosomes for Expanded Access Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cellphire, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cellphire, Inc.</source>
  <brief_summary>
    <textblock>
      Expanded use of Thrombosomes where a clinical trial with Thrombosomes is not an option,&#xD;
      Cellphire may elect to provide the Sponsor/Investigator (S/I) expanded access to its&#xD;
      investigational product, Thrombosomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <has_expanded_access>No</has_expanded_access>
  <expanded_access_info>
    <expanded_access_type_individual>Yes</expanded_access_type_individual>
  </expanded_access_info>
  <condition>Bleeding</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ThrombosomesÂ®</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject has presented with WHO Grade 2 or higher bleeding which requires treatment&#xD;
             with platelet therapy and there is limited availability of platelets or no other&#xD;
             approved clinical alternative.&#xD;
&#xD;
          2. Evidence from the facility blood bank/Medical Director that there are no approved&#xD;
             platelet products available for transfusion, or the patient is refractory to platelet&#xD;
             transfusion.&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
          3. Clinical circumstances of a history of thrombosis, thromboembolism, or vascular&#xD;
             occlusion/ischemia in the prior six months such as defined by a past history of&#xD;
             current diagnosis of one or more of the following:&#xD;
&#xD;
               -  arterial or venous thromboembolic disease including acute coronary syndrome&#xD;
&#xD;
               -  peripheral vascular disease&#xD;
&#xD;
               -  arterial or venous thrombosis (except when a prior history of central line&#xD;
                  thrombosis has resolved)&#xD;
&#xD;
               -  myocardial infarction (MI)&#xD;
&#xD;
               -  stent placement&#xD;
&#xD;
               -  valve replacement and/or repair&#xD;
&#xD;
               -  sinusoidal obstruction syndrome (veno-occlusive disease)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Mike Fitzpatrick, PhD</last_name>
    <phone>301-545-2528</phone>
    <email>expandedaccess@cellphire.com</email>
  </overall_contact>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 2, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2020</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

